$0.0310
0.0034812.65%
At close: -
Comments
Loading...
Latest news for Galera Therapeutics (OTC:GRTX) Stock
Galera Therapeutics Stock (OTC: GRTX)
Categories: All
Monday, June 03, 2024
- Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Why Galera Therapeutics (GRTX) Stock Is Nosediving
- Galera Therapeutics shares are trading lower ...
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Galera Therapeutics To Be Delisted By Nasdaq,...
Wednesday, May 29, 2024
Monday, May 13, 2024
Friday, May 03, 2024
Friday, April 26, 2024
Friday, April 19, 2024
Wednesday, April 17, 2024
Monday, April 01, 2024
Friday, March 29, 2024
Thursday, March 28, 2024
Wednesday, March 27, 2024
Tuesday, February 27, 2024
Monday, February 26, 2024
Thursday, January 11, 2024
Wednesday, January 10, 2024
Tuesday, January 09, 2024
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Dow Tumbles Over 200 Points; US Trade Gap Narrows In November
- Why Juniper Networks Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Tuesday, November 14, 2023
Monday, November 13, 2023
Thursday, November 02, 2023
Tuesday, October 31, 2023
- Dow Gains 50 Points; Global Payments Posts Upbeat Earnings
- Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Crude Oil Edges Higher; Caterpillar Earnings Top Views
- Galera Therapeutics shares are trading lower ...
- Why Is Cancer Focused Galera Therapeutics Stock Sinking Today?
- US Stocks Fall; Pfizer Swings To Q3 Loss
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Galera Therapeutics says GRECO-2 Trial Did No...